Quantum Biopharma (QNTM) Receivables (2018 - 2025)
Quantum Biopharma recorded quarterly Receivables of $462106.0 in Q4 2025, down 38.33% quarter-over-quarter from $749356.0 in Q4 2024, and down 38.33% year-over-year from $749356.0 in Q4 2024.
Quantum Biopharma's Receivables history runs 8 years deep, the most recent figure standing at $462106.0 for Q4 2025.
- In Q4 2025, Receivables fell 38.33% year-over-year to $462106.0; the TTM figure through Dec 2025 stood at $462106.0 (down 38.33% YoY), while the FY2025 annual figure was $462106.0, down 38.33% from the prior year.
- Receivables came in at $462106.0 for Q4 2025 at Quantum Biopharma, down from $749356.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $749356.0 in Q4 2024 to a low of -$341916.0 in Q2 2021.
- A 5-year average of $289473.0 and a median of $459817.0 in 2023 frame the typical range for Receivables.
- On a YoY basis, Receivables climbed as much as 166.52% in 2021 and fell as far as 170.39% in 2021.
- Quantum Biopharma's Receivables stood at $500964.0 in 2021, then jumped by 49.46% to $748754.0 in 2022, then sank by 38.89% to $457528.0 in 2023, then jumped by 63.78% to $749356.0 in 2024, then sank by 38.33% to $462106.0 in 2025.
- According to Business Quant data, Receivables over the past three periods registered $462106.0, $749356.0, and $457528.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 13.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 4.15 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2.00 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 5.73 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 883.96 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 462,106.00 |
| Dec 31, 2024 | 749,356.00 |
| Dec 31, 2023 | 457,528.00 |
| Dec 31, 2022 | 748,754.00 |
| Dec 31, 2021 | 500,964.00 |
| Sep 30, 2021 | -208,114.00 |
| Jun 30, 2021 | -341,916.00 |
| Mar 31, 2021 | -52,894.00 |
| Dec 31, 2020 | 187,967.00 |
| Jun 30, 2020 | 485,760.43 |
| Mar 31, 2020 | -444,605.39 |
| Dec 31, 2019 | 1.59 Mn |
| Mar 31, 2019 | 124,156.46 |
| Dec 31, 2018 | 750,792.12 |